Organon & Co.
NYSE:OGN
| Market Cap (Intraday) | 4.72B |
| Current PE | 4.72 |
| Forward PE | 4.19 |
| 2yr Forward PE | 4.02 |
| 10-Day MA | $18.95 |
| 50-Day MA | $20.44 |
| 200-Day MA | $18.68 |
Organon & Co. Stock, NYSE:OGN
30 Hudson Street, 33rd floor, Jersey City, New Jersey 07302
United States of America
Phone: +1.551.430.6900
Number of Employees: 10000
Description
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women�s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.